PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $84.0M | $43.0M |
| FY2014 | — | $117.0M | $38.5M |
| FY2015 | — | $206.0M | $31.6M |
| FY2016 | — | $209.8M | $194.5M |
| FY2017 | $48.5M | $53.3M | $81.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $84.0M | $43.0M |
| FY2014 | — | $117.0M | $38.5M |
| FY2015 | — | $206.0M | $31.6M |
| FY2016 | — | $209.8M | $194.5M |
| FY2017 | $48.5M | $53.3M | $81.7M |